Friend or foe? The elusive role of hepatic stellate cells in liver cancer

B Cogliati, CN Yashaswini, S Wang, D Sia… - Nature Reviews …, 2023 - nature.com
Liver fibrosis is a substantial risk factor for the development and progression of liver cancer,
which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma …

[HTML][HTML] Immune system and hepatocellular carcinoma (HCC): new insights into HCC progression

M Kotsari, V Dimopoulou, J Koskinas… - International Journal of …, 2023 - mdpi.com
According to the WHO's recently released worldwide cancer data for 2020, liver cancer
ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular …

[HTML][HTML] An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

L Wu, J Yan, Y Bai, F Chen, X Zou, J Xu, A Huang… - Cell research, 2023 - nature.com
Dissecting and understanding the cancer ecosystem, especially that around the tumor
margins, which have strong implications for tumor cell infiltration and invasion, are essential …

FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2

M Xie, Z Lin, X Ji, X Luo, Z Zhang, M Sun, X Chen… - Journal of …, 2023 - Elsevier
Abstract Background & Aims Metastasis remains the major reason for high mortality of HCC
patients. This study was designed to investigate the role of E-twenty-six-specific sequence …

Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision making

R Dhanasekaran, H Suzuki, L Lemaitre, N Kubota… - Hepatology, 2023 - journals.lww.com
Liver cancer, primarily hepatocellular carcinoma (HCC), exhibits highly heterogeneous
histological and molecular aberrations across tumors and within individual tumor nodules …

[HTML][HTML] Immunosuppressive CD10+ ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells

Y Meng, F Ye, P Nie, Q Zhao, L An, W Wang, S Qu… - Journal of …, 2023 - Elsevier
Background & Aims Remodeling the tumor microenvironment is a critical strategy for treating
advanced hepatocellular carcinoma (HCC). Yet, how distinct cell populations in the …

Gold Nanorod–mesoporous silica core shell nanocomposites for NIR-II photothermal ablation and dual PD-L1/VEGF blockade therapy in hepatocellular carcinoma

X Dai, X Li, Y Du, M Han, Z Wang, Y Wang… - Chemical Engineering …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is a common malignancy often associated with high
angiogenesis and immune suppression in the tumor microenvironment (TME). Targeting of …

[HTML][HTML] The liver cancer immune microenvironment: emerging concepts for myeloid cell profiling with diagnostic and therapeutic implications

K Arvanitakis, I Mitroulis, A Chatzigeorgiou… - Cancers, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. To date, systemic treatment for patients with unresectable or advanced disease …

[HTML][HTML] Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Y Chen, W Wang, MP Morgan, T Robson… - Frontiers in …, 2023 - frontiersin.org
Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for
numerous cancers, including hepatocellular carcinoma (HCC), the third leading cause of …

[HTML][HTML] Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment

Z Gao, SR Feng, JF Chen, XG Li, YH Shi, Z Tang… - Biomedicine & …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) has a complex and changeable tumor microenvironment.
Despite emerging evidence focusing on autophagy process within immune cells, the …